Otoband

DEVICE6 trials

Sponsors

Otolith Labs

Conditions

Chemotherapy-induced Nausea and VomitingConfusionDizzinessHeadacheLabyrinthitisNauseaNausea Post ChemotherapyTinnitus

Unknown Phase

Efficacy of a Transcranial Vibrating System for Mitigation of Migraine Associated Vertigo

SuspendedNCT03886012

Otolith LabsConfusion, Dizziness, Headache +1

Start: 2019-04-26End: 2021-12-30Target: 40Updated: 2021-04-27

Prevention of Unmitigated Chemotherapy-induced Emesis

WithdrawnNCT03996863

Otolith LabsChemotherapy-induced Nausea and Vomiting, Nausea Post Chemotherapy

Start: 2019-08-01End: 2019-08-01Updated: 2021-04-27

Efficacy of a Non-invasive Vestibular System Masking for Improving Outcomes Following Acute Unilateral Vestibulopathy

SuspendedNCT04226976

Otolith LabsDizziness, Nausea

Start: 2022-06-01End: 2024-06-30Target: 40Updated: 2022-03-22

Evaluation of the OtoBand as a Treatment to Reduce the Perceived Loudness of Tinnitus

Otolith LabsTinnitus

Start: 2021-03-05End: 2024-02-28Target: 40Updated: 2022-03-22

Evaluation of the OtoBand in Subjects With Self-reported Vertigo to Reduce Severity of Vertigo in a Real-world Setting

CompletedNCT04869020

Otolith LabsVertigo

Start: 2021-04-19End: 2022-11-26Updated: 2025-07-17

Quantification of the Effect of the OtoBand on Objective Measures of Vertigo and Dizziness

CompletedNCT05157399

Otolith LabsDizziness, Labyrinthitis, Vertigo +2

Start: 2021-11-04End: 2022-09-01Updated: 2022-11-15